CD274 and neoplasm: These novel imaging biomarkers might be correlated with a panel of diagnostic, prognostic and predictive biomarkers, either immunohistochemical (ie PD‐L1), serological (ie Lactate Dehydrogenase, LDH) and molecular (ie tumor mutational burden, TMB), proposed in literature55, 56 for support the management of advanced stage melanoma patients.